Voyager Therapeutics (VYGR) Revenue Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3,790.58% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -60.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.11% |
| Dec 31, 2025 | 143.99% |
| Sep 30, 2025 | -45.59% |
| Jun 30, 2025 | -82.43% |
| Mar 31, 2025 | -66.67% |
| Dec 31, 2024 | -93.01% |
| Sep 30, 2024 | 435.41% |
| Jun 30, 2024 | 504.08% |
| Mar 31, 2024 | -87.04% |
| Dec 31, 2023 | 5,913.42% |
| Sep 30, 2023 | -88.80% |
| Jun 30, 2023 | 588.20% |
| Mar 31, 2023 | 22,769.30% |
| Dec 31, 2022 | -105.52% |
| Sep 30, 2022 | 2,672.33% |
| Jun 30, 2022 | -47.53% |
| Mar 31, 2022 | -89.88% |
| Dec 31, 2021 | 329.45% |
| Sep 30, 2021 | -98.74% |
| Jun 30, 2021 | -95.27% |
| Mar 31, 2021 | -64.02% |
| Dec 31, 2020 | -79.99% |
| Sep 30, 2020 | 476.73% |
| Jun 30, 2020 | -37.77% |
| Mar 31, 2020 | 247.64% |
| Dec 31, 2019 | 1,527.19% |
| Sep 30, 2019 | 875.79% |
| Jun 30, 2019 | 1,689.79% |
| Mar 31, 2019 | 451.70% |
| Dec 31, 2018 | -68.36% |
| Sep 30, 2018 | 82.40% |
| Jun 30, 2018 | 118.78% |
| Mar 31, 2018 | -35.66% |
| Dec 31, 2017 | 168.67% |
| Sep 30, 2017 | -65.30% |
| Jun 30, 2017 | -68.36% |
| Mar 31, 2017 | -69.69% |
| Dec 31, 2016 | -52.16% |
| Sep 30, 2016 | -33.00% |
| Jun 30, 2016 | -23.83% |
| Mar 31, 2016 | 87.50% |